CF CAN TRANSCATHETER HEART VALVE REPAIR, REPLACEMENT AND ASSOCIATED DEVICES

Supply Chain Coordination Limited · awarded 21 February 2023

£880.0m Award value £880,000,000
12 Suppliers Recorded as a large business
17 Sep 2027 Runs until from 18 Sep 2023

Who

BuyerSupply Chain Coordination Limited London
Suppliers Abbott Medical U.K.Ltd
Acrostak-UK Ltd
BIOSENSORS INTERNATIONAL UK LIMITED
BVM MEDICAL LTD
Boston Scientific Ltd
Dot Medical Limited
Edwards Lifesciences Ltd
JenaValve Production Ltd.
MCT Lifesciences Ltd
Medtronic Limited
Meril UK Pvt Ltd
SAHAJANAND MEDICAL TECHNOLOGIES (SMT) UK
Categorygoods
ClassificationMedical equipments CPV 33100000
Notice published10 June 2025

What it is for

NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply of percutaneous valve repair and replacement devices to NHS Supply Chain customers via the non-direct route of supply. Certain products within this framework agreement are classified as high cost tariff excluded devices under the NHS England Specialised Services Devices Programme (SSDP) (formerly known as the High-Cost Tariff-Excluded Devices programme) . Trusts who are commissioned to provide specialised services in England are directed to purchase all their SSDP requirements through a national supply route via NHS Supply Chain. It is anticipated that initial expenditure will be in the region of £130,000,000 to £160,000,000 in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £880,000,000

Read the original award notice on Contracts Finder →

Other contracts from this buyer

37 awards on file, worth £13.6bn.

Everything Supply Chain Coordination Limited has awarded →

Other contracts won by this supplier

1 award on file, worth £880.0m.

Everything Abbott Medical U.K.Ltd has won →